MFAP2 and paraganglioma: In this sense, opposite gene expression levels of MFAP2 have been described in different tumour types as being upregulated in gastric [25], thyroid [33] and hepatocellular [34] carcinomas and downregulated in prostate carcinoma and paragangliomas [35].